Sichenzia Ross Ference LLP represented Lexaria Bioscience Corp. in the transaction. Lexaria Bioscience Corp. (NASDAQ: “LEXX”) closed an underwritten public offering of 1,828,571 units, each unit…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now